IP Library › Assignment 039206/0091
Patent Assignment
Reel/Frame 039206/0091

Change of Name

Recorded: 2016-06-29 Pages: 4
Assignor
SYNTONIX PHARMACEUTICALS, INC.
Executed: 2010-05-19
Assignee
BIOGEN IDEC HEMOPHILIA INC.
250 BINNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (3)
PC5 as a Factor Ix Propeptide Processing Enzyme
Patent: 7,566,565 →
Application: 11/728,045 →
Publication: US 2007/0259402
PC5 as a Factor Ix Propeptide Processing Enzyme
Patent: 7,795,400 →
Application: 12/489,391 →
Publication: US 2010/0015659
PC5 as a Factor Ix Propeptide Processing Enzyme
Patent: 8,021,880 →
Application: 12/841,072 →
Publication: US 2011/0053222
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 20, 2007
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 019188/0413 →
Corrective Assignment to Correct the State of Incorporation of Assignee Previously Recorded on Reel 019188 Frame 0413. Assignor(S) Hereby Confirms the Assignment of Us Serial No. 11/728045. Jun 8, 2007
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 019398/0693 →
Assignment of Assignor's Interest Nov 16, 2009
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 023522/0317 →
Assignment of Assignor's Interest Jan 24, 2011
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 025683/0115 →
Change of Name Jan 31, 2017
From: BIOGEN IDEC HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 041578/0743 →
Change of Name Feb 16, 2017
From: BIOGEN HEMOPHILIA INC.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 041735/0671 →